22. Alp S., Skrygan M., Schmidt W.E., Bashan A. Sildenafil improvts hemodynamic parametes in COPO-an investigate of six patients // Pulm. Pharmacol. Ther.– 2006.– Vol. 19 (6).– P. 386-390.

23. Barst R.J., Rich S., Widlitz A. et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension // Chest.– 2002.– 121.– P. 1860-1868.

24. Becattini C., Agnelli G., Pesavento R. et al. Incidence of chronic thromboembolie pulmonary hypertension after a first episode of pulmonary embolism // Chest.– 2006.– 130.– P. 172-175.

25. Block P.C., Palacios J.F., Block E.N. et al. Two-year follow-up after percutaneous balloon mitral valvotomy // J. Am. Coll. Cardiol.– 1991.– Vol. 69.– Р. 537.

26. Cournand A. Control of the Pulmonary Circulation in Normal Man.Proc. of the Harvey Tercentenery Congress. Oxford: Blackwell Scientific Publications, 1958.– P. 219-237.

27. Currie P.J., Seward J.B., Chanki R. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Dopplercatheterization study in 127 patients // J. Am Coll. Cardiol.– 1985.– 6.– P. 750-756.

28. Dalen J.E. Pulmonary embolism: what have we learned since Virchow? Natural history, patophysiology, and diagnosis // Chest.– 2002.– 122.– P. 1440-1456.

29. Fishman A.P. Respiratory gases in the regulation of the pulmonary circulation // Physiol. Rev.– 1961.– 41.– P. 214-279.

30. Forssmann W. Die Sondeierung des rechten Herzen.– Klin. Wochnschr.– 1929.– 8.– P. 2085-2087.

31. Frank H. et al. The effect of anticoagulant therapy in primary and anorectic drug-inducend pulmonary hypertension // Chest.– 1997.– Vol. 112.– P. 714-721.

32. Fuster V. et al. Primary pulmonary hypertension natural history and the importance of thrombosis // Circulation.– 1984.– Vol. 70.– P. 580-587.

33. Galie N., Torbicki A., Barst R. et al. the Task Forse on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the Europen Society of Cardiology. Guidelines on Diagnosis and Treatment of Pulmonary Arterial Hypertension // Eur. Heart J.– 2004.– 25.– P. 2243-2278.

34. Kearon C. Natural history of venous thromboembolism // Circulation.– 2003.– 107 (2, suppl. 1).– P. 122-130.

35. Kelly M. Chin, Levis J. Rubin Легочная артериальная гипертензия // Jacc.– 2008.– 20-31.

36. Kwan R., Afzal M. Beneficial effects of dietary carbohydrate restriction in chronic cor pulmonale // Am. J. Med.– 1987.– 82.– 751-758.

37. Meneveau N., F. Schiele, M. F. et al. Second рredictors of event-free survival after percutaneous mitral commissurotomy // Heart.– 1998.– Vol. 80, N 4.– P. 359-364.

38. Michelakis E.D., Tymchak W., Noda M. et al. Long-Term Treatment With Oral Sildenafil is Safe and improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension // Circulation.– 2003.– Vol. 108.– P. 2006-209.

39. Migueres M., Escamillia R., Coca F. et al. Pulsed Doppler echocardiography in diagnosis of COPD // Chest.– 1990.– 98 .– P. 280-285.

40. Olschewski H., Hoeper M.M., Borst M.M. et al. Diagnostik und Therapie der chronischen pulmonalen Hypertonie. DOI 10,1055/s // Pnheumologie.– 2006.– 60.– P. 749-771.

41. Pengo V., Lensing A.W., Prins M.H. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism // N. Engl. J. Med.– 2004.– 350.– P. 2257-2264.

42. Rich S., Kaufman E., Levy P.S. The effect of high dosed of calciumchannel blockers on survival in primary pulmonary hypertension // New Engl. J. Med.– 1992.– Vol. 327.– P. 76-81.

43. Rich S., Braunwald E., Grossman W. Pulmonary hypertension // Heart disease. A textbook of cardiovascular medicine / Ed. E. Braunwald.– Philadelphia, 1997.– P. 780-806.

44. Rubin L.J., Badesch D.B., Barst R.J. et al. Bosentan therapy for pulmonary arterial hypertension // N. Engl. J. Med.– 2002.– 346.– P. 896-903.